title: Are study dropouts different from completers?
authors.affiliation: Depression Research Program program, Massachusetts General Hospital, Boston 02114, USA.
authors.forename: J R
authors.initials: JR
authors.lastname: Tedlow
authors.forename: M
authors.initials: M
authors.lastname: Fava
authors.forename: L A
authors.initials: LA
authors.lastname: Uebelacker
authors.forename: J E
authors.initials: JE
authors.lastname: Alpert
authors.forename: A A
authors.initials: AA
authors.lastname: Nierenberg
authors.forename: J F
authors.initials: JF
authors.lastname: Rosenbaum
mesh_terms: D000328:Adult; D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects / Q000627:therapeutic use*; D015897:Comorbidity; D003866:Depressive Disorder / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D005260:Female; D005473:Fluoxetine / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010352:Patient Dropouts / Q000523:psychology*; D010554:Personality Disorders / Q000175:diagnosis / Q000188:drug therapy / Q000523:psychology; D011569:Psychiatric Status Rating Scales
chemical_list: D018687:Antidepressive Agents, Second-Generation; D005473:Fluoxetine